An experimental drug for treatment of chronic constipation met its main and secondary goals, when compared with a placebo, Synergy Pharmaceuticals reported. Results from the 12-week study showed that more patients on Synergy's drug plecanatide had a complete emptying of bowels, compared with those on a placebo.

Full Story:

Related Summaries